GenoGra

Private

MilanHealthcare & Life Scienceshttps://genogra.com/

Last Round

Pre Seed

Feb 16, 2026

Total Funding Raised

$1.19M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

GenoGra is a biotechnology company that develops a pangenomic software platform designed for faster and more accurate interpretation of genetic data.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Vertical SaaS, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

pangenomic analysisgenome graphspangenome softwarebioinformatics platformnon-human genomicspangenome graphsgenome graph analysispopulation genomicsgenomic data analysisagricultural genomicslivestock genomicsgenomic analysis softwaregenomic data visualizationclinical genomicsprecision medicineindustrial microbiology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenoGra Comps

Public and private peers based on sector, stage, and business model.

GenoGra comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GenoGra Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Pre Seed	Feb 16, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Guido Walter Di Donato

Chief Executive Officer & Founder

Founding Team

Alessandro Vingione

Chief Operating Officer, Board Member

Executive Team

GenoGra Investors

Notable investors and investment history

GenoGra investors
Investor	Rounds
Intesa Sanpaolo Innovation Center	Pre Seed
European Investment Fund	Pre Seed
Terra Next Accelerator	Pre Seed
Maia Ventures	Pre Seed
CDP Venture Capital SGR	Pre Seed
PM Holding	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 22, 2026
Grew 63% QoQ, from 8 to 13 employees.
Apr 6, 2026
Monthly visitors increased 191% MoM.

View all signals

GenoGra Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

GenoGra Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GenoGra's valuation, stock price, and market status.

Firmographic Details

HeadquartersMilan

Employee Range13

Year Founded2023

Last FundingFeb 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.